These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 2785850)
1. Immunotoxin-mediated inhibition of chronic lymphocytic leukemia cell proliferation in humans. Siena S; Bregni M; Formosa A; Brando B; Marenco P; Lappi DA; Bonadonna G; Gianni AM Cancer Res; 1989 Jun; 49(12):3328-32. PubMed ID: 2785850 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and characterization of an antihuman T-lymphocyte saporin immunotoxin (OKT1-SAP) with in vivo stability into nonhuman primates. Siena S; Lappi DA; Bregni M; Formosa A; Villa S; Soria M; Bonadonna G; Gianni AM Blood; 1988 Aug; 72(2):756-65. PubMed ID: 3042047 [TBL] [Abstract][Full Text] [Related]
3. Cytotoxic activity of an anti-transferrin receptor immunotoxin on normal and leukemic human hematopoietic progenitors. Cazzola M; Bergamaschi G; Dezza L; D'Uva R; Ponchio L; Rosti V; Ascari E Cancer Res; 1991 Jan; 51(2):536-41. PubMed ID: 1985771 [TBL] [Abstract][Full Text] [Related]
4. An immunotoxin composed of monoclonal anti-Thy 1.1 antibody and a ribosome-inactivating protein from Saponaria officinalis: potent antitumor effects in vitro and in vivo. Thorpe PE; Brown AN; Bremner JA; Foxwell BM; Stirpe F J Natl Cancer Inst; 1985 Jul; 75(1):151-9. PubMed ID: 3859688 [TBL] [Abstract][Full Text] [Related]
5. Immunotoxin mediated killing of clonable T-lymphocytes infiltrating an irreversibly rejected human renal allograft. Siena S; Bregni M; Formosa A; Brando B; Lappi DA; Bonadonna G; Gianni AM J Biol Regul Homeost Agents; 1989; 3(2):84-8. PubMed ID: 2479229 [TBL] [Abstract][Full Text] [Related]
6. B-cell restricted saporin immunotoxins: activity against B-cell lines and chronic lymphocytic leukemia cells. Bregni M; Siena S; Formosa A; Lappi DA; Martineau D; Malavasi F; Dorken B; Bonadonna G; Gianni AM Blood; 1989 Feb; 73(3):753-62. PubMed ID: 2465042 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of growth of breast cancer cells in vitro by the ribosome-inactivating protein saporin 6. Gasperi-Campani A; Zoli W; Volpi A; Roncuzzi L; Amadori D Anticancer Res; 1991; 11(2):1007-11. PubMed ID: 2064307 [TBL] [Abstract][Full Text] [Related]
8. Therapy of human T-cell acute lymphoblastic leukaemia with a combination of anti-CD7 and anti-CD38-SAPORIN immunotoxins is significantly better than therapy with each individual immunotoxin. Flavell DJ; Boehm DA; Noss A; Warnes SL; Flavell SU Br J Cancer; 2001 Feb; 84(4):571-8. PubMed ID: 11207056 [TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo efficacy of heat shock protein specific immunotoxins on human tumor cells. Piselli P; Vendetti S; Poccia F; Cicconi R; Mattei M; Bolognesi A; Stirpe F; Colizzi V J Biol Regul Homeost Agents; 1995; 9(2):55-62. PubMed ID: 9127634 [TBL] [Abstract][Full Text] [Related]
10. In vitro bone marrow purging of multidrug-resistant cells with a mouse monoclonal antibody directed against Mr 170,000 glycoprotein and a saporin-conjugated anti-mouse antibody. Dinota A; Tazzari PL; Michieli M; Visani G; Gobbi M; Bontadini A; Tassi C; Fanin R; Damiani D; Grandi M Cancer Res; 1990 Jul; 50(14):4291-4. PubMed ID: 1694719 [TBL] [Abstract][Full Text] [Related]
11. Initial experience in treating human lymphoma with a combination of bispecific antibody and saporin. Bonardi MA; Bell A; French RR; Gromo G; Hamblin T; Modena D; Tutt AL; Glennie MJ Int J Cancer Suppl; 1992; 7():73-7. PubMed ID: 1428411 [TBL] [Abstract][Full Text] [Related]
12. The anti-CD20 antibody rituximab augments the immunospecific therapeutic effectiveness of an anti-CD19 immunotoxin directed against human B-cell lymphoma. Flavell DJ; Warnes SL; Bryson CJ; Field SA; Noss AL; Packham G; Flavell SU Br J Haematol; 2006 Jul; 134(2):157-70. PubMed ID: 16771848 [TBL] [Abstract][Full Text] [Related]
13. The conjugate Rituximab/saporin-S6 completely inhibits clonogenic growth of CD20-expressing cells and produces a synergistic toxic effect with Fludarabine. Polito L; Bolognesi A; Tazzari PL; Farini V; Lubelli C; Zinzani PL; Ricci F; Stirpe F Leukemia; 2004 Jul; 18(7):1215-22. PubMed ID: 15103391 [TBL] [Abstract][Full Text] [Related]
14. Cytotoxic effects of basic FGF and heparin binding EGF conjugated with cytotoxin saporin on vascular cell cultures. Chen C; Li J; Micko CJ; Pierce GF; Cunningham MR; Lumsden AB J Surg Res; 1998 Feb; 75(1):35-41. PubMed ID: 9614854 [TBL] [Abstract][Full Text] [Related]
15. Antitumor activity of basic fibroblast growth factor-saporin mitotoxin in vitro and in vivo. Beitz JG; Davol P; Clark JW; Kato J; Medina M; Frackelton AR; Lappi DA; Baird A; Calabresi P Cancer Res; 1992 Jan; 52(1):227-30. PubMed ID: 1309225 [TBL] [Abstract][Full Text] [Related]
16. Prevention of growth of leukemia cells in mice by monoclonal antibodies directed against Thy 1.1 antigen disulfide linked to two ribosomal inhibitors:pokeweed antiviral protein or ricin A chain. Ramakrishnan S; Houston LL Cancer Res; 1984 Apr; 44(4):1398-404. PubMed ID: 6142765 [TBL] [Abstract][Full Text] [Related]
17. Selection and characterization of early hematopoietic progenitors using an anti-CD71/S06 immunotoxin. Benedetti G; Bondesan P; Caracciolo D; Cherasco C; Ruggieri D; Gastaldi ME; Pileri A; Gianni AM; Tarella C Exp Hematol; 1994 Feb; 22(2):166-73. PubMed ID: 7507858 [TBL] [Abstract][Full Text] [Related]
18. Cooperative mixtures of bispecific F(ab')2 antibodies for delivering saporin to lymphoma in vitro and in vivo. French RR; Courtenay AE; Ingamells S; Stevenson GT; Glennie MJ Cancer Res; 1991 May; 51(9):2353-61. PubMed ID: 2015599 [TBL] [Abstract][Full Text] [Related]
19. Thermo-stability and antitumor activity on colon cancer cell lines of monoclonal anti-CEA antibody-saporin immunotoxin. Manosroi J; von Kleist S; Manosroi A; Grunert F J Korean Med Sci; 1992 Jun; 7(2):128-35. PubMed ID: 1524725 [TBL] [Abstract][Full Text] [Related]